CXXC5 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma (ESCC), upregulated miR-32 can target the 3'-UTR of CXXC5 to inhibit CXXC5 expression and is associated with increased capacity of migration, invasion and adhesion in ESCC [38].